CompletedNCT01866098
Naltrexone for Antipsychotic-Associated Weight Gain in Serious Mental Illness
About this title
Read the official source — NCT01866098Medication studyAges 18–75United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- New HavenSee all locations and recruitment
Study information
Study start dateMay 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 144
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT01866098
- Official title
Show the full official title
Naltrexone for Antipsychotic-Induced Weight Gain
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Did this study involve medication?
Yes. The study involved medication, including Naltrexone and Placebo.
Who was this study for?
Listed age limits: 18 years to 75 years.
